Omosalewa Adenikinju, MD

Clinical Update

The STAND Trial: How the MicroStent Attempts to Break Through Barriers in Below-the-Knee CLI

05/21/2020

Robert E. Beasley , MD, FSCAI, FSIR;

Adam Zybulewski , MD;

Brandon P. Olivieri , MD, RPVI;

Michael Patel , MD;

Omosalewa Adenikinju , MD;

To understand the intent behind the STAND (Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in Subjects with Arterial Disease Below the Knee) trial, one must comprehend the barriers of clinical success in BTK revascularization.

To understand the intent behind...

05/21/2020

Vascular Disease Management

Endovascular Therapies

CFA, Profunda, and SFA Disease: Is There a Role for Endovascular Reconstruction When a Patient is Not a Surgical Candidate?

11/19/2018

Timothy E. Yates , MD, RPVI;

Omosalewa Adenikinju , MD;

Brandon P. Olivieri , MD, RPVI;

Sofia D.C. Vianna , MD;

Robert E. Beasley , MD, FSCAI, FSIR;

Available data suggest that common femoral artery atherosclerosis with or without patch angioplasty has a high 5-year patency rate and a relatively low rate of postoperative complications.

Available data suggest that...

11/19/2018

Vascular Disease Management

Clinical Review

Uterine Fibroid Embolization: A Review for Endovascular Trainees

04/19/2021

Omosalewa Adenikinju , MD;

Adam Zybulewski , MD;

Brandon P. Olivieri , MD, RPVI;

Kiran C. Patel ;

Robert E. Beasley , MD, FSCAI, FSIR;

Daniel Rubin , DO;

Brad Money , BS;

Fibroids are the most common benign tumor in women of reproductive age, and the most common pelvic tumor overall in women. They arise from smooth muscle cells and fibroblasts in the myometrium.

Fibroids are the most common...

04/19/2021

Vascular Disease Management